Quality
Quality Management
Raysun is developing its pharmaceutical quality management system in parallel with the design, construction, commissioning and qualification of the Vientiane facility. The system is intended to translate Quality by Design principles into controlled procedures, records, responsibilities and risk-based decision-making across development, technology transfer and manufacturing readiness.
Implementation will be phased and evidence-based. Processes will be released for operational use only after the relevant facilities, equipment, utilities, methods, computerized systems and personnel have completed the applicable qualification, validation or training activities.
- Pharmaceutical Quality System
- Document and Data Governance
- Laboratory Control and Analytical Lifecycle
- Materials and Supplier Management
- Production and Packaging Controls
- Facilities, Utilities and Equipment
- Deviation, Change Control and CAPA
Each element will be managed through documented lifecycle controls and periodic management review. Final GMP scope, batch-release responsibilities and regulatory status will be confirmed only after completion of the required qualification, validation and applicable regulatory authorization.
Document Hierarchy & Control
A Four-Level Quality Documentation Framework
Quality Documentation & Lifecycle Controls
| Quality System Area | What It Covers |
|---|---|
| Quality Manual & Policies | Quality governance, responsibilities and management commitments |
| Procedures & SOPs | Controlled instructions supporting consistent execution |
| Specifications & Methods | Approved material, process and analytical requirements |
| Protocols & Reports | Qualification, validation and study planning with documented conclusions |
| Batch & Laboratory Records | Traceable and contemporaneous manufacturing and testing records |
| Change Control | Risk-based assessment, approval, implementation and effectiveness review |
| Deviation / OOS / OOT & CAPA | Investigation, root-cause analysis and corrective or preventive action |
| Training & Competency | Role-based training, qualification and continuing competency records |
| Document & Data Lifecycle | Controlled creation, review, issuance, revision, retention and archival |
Analytical Quality Control
Testing Strategy & Release Readiness
Analytical control strategies will be established according to the product, development phase, intended market and agreed manufacturing scope. Test methods, specifications and release responsibilities will be defined through documented technical and quality review.
- Identity and molecular characterization
- Assay, purity and related-substance testing
- Residual solvents and process-related impurities
- Moisture and physicochemical attributes
- Bioburden and endotoxin testing, where applicable
- Stability-indicating methods and stability-program support
- Analytical method qualification, validation and transfer
- Controlled sampling, data review and OOS/OOT investigation
- Certificate of Analysis and release documentation, where authorized
Regulatory & CMC Readiness
CMC & Quality Documentation Support
Raysun plans coordinated quality and CMC documentation support for development, technology-transfer and manufacturing-readiness programs. Final deliverables will be defined according to the project scope, available evidence and applicable regulatory requirements.
- CMC data-package planning and document coordination
- Quality target product profile and critical-quality-attribute review
- Specifications, analytical methods and technical justifications
- Manufacturing records and process-control documentation
- Qualification, validation and stability reports
- Deviation, change-control and CAPA summaries
- Comparability and technology-transfer documentation
- Audit and regulatory-inspection readiness support
Service Coverage
Integrated Quality & Manufacturing Support
Quality, analytical and documentation support is coordinated with the technical scope and lifecycle stage of each accepted program.
| Capability Area | Availability | Integrated Support |
|---|---|---|
| Peptide API Programs | Available | Route development, process optimization, purification, analytical control and GMP manufacturing. |
| Oligonucleotide Programs | Available | Process development, impurity strategy, analytical support, sterile formulation and supply. |
| Growth Hormone API & FDF | Available | API development, formulation, finished dosage-form and lifecycle manufacturing support. |
| Sterile Drug Products | Available | Formulation, presentation selection, fill-finish, compatibility and quality control. |
| Analytical & Quality Services | Available | Method development, validation, stability, documentation and release support. |
| Technology Transfer & Regulatory Support | Available | Transfer planning, validation strategy, regulatory documentation and lifecycle coordination. |
Final methods, specifications, release responsibilities, manufacturing arrangements and regulatory deliverables are confirmed through project-specific technical and quality review.
Facility qualification, validation, GMP status and operating scope remain subject to documented completion and applicable regulatory authorization.